MIRA INFORM REPORT

 

 

Report No. :

337421

Report Date :

21.08.2015

 

IDENTIFICATION DETAILS

 

Name :

ANZCHEM PTY LTD

 

 

Registered Office :

'Building A' Level 1, 11 Talavera Road North Ryde Nsw, 2113

 

 

Country :

Australia

 

 

Financials (as on) :

31.08.2014

 

 

Date of Incorporation :

30.12.2002

 

 

Legal Form :

Private company

 

 

Line of Business :

Subject operates as a supplier of pharmaceuticals, veterinarian and food ingredient products.

 

 

No. of Employee :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Australia

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

AUSTRALIA ECONOMIC OVERVIEW

 

Following two decades of continuous growth, low unemployment, contained inflation, very low public debt, and a strong and stable financial system, Australia enters 2015 facing a range of growth constraints, principally driven by a sharp fall in global prices of key export commodities. Although demand for resources and energy from Asia and especially China has grown rapidly, creating a channel for resources investments and growth in commodity exports, sharp drops in current prices have already impacted growth. The services sector is the largest part of the Australian economy, accounting for about 70% of GDP and 75% of jobs. Australia was comparatively unaffected by the global financial crisis as the banking system has remained strong and inflation is under control. Australia has benefited from a dramatic surge in its terms of trade in recent years, although this trend could reverse or slow due to falling global commodity prices. Australia is a significant exporter of natural resources, energy, and food. Australia's abundant and diverse natural resources attract high levels of foreign investment and include extensive reserves of coal, iron, copper, gold, natural gas, uranium, and renewable energy sources. A series of major investments, such as the US$40 billion Gorgon Liquid Natural Gas project, will significantly expand the resources sector. Australia is an open market with minimal restrictions on imports of goods and services. The process of opening up has increased productivity, stimulated growth, and made the economy more flexible and dynamic. Australia plays an active role in the World Trade Organization, APEC, the G20, and other trade forums. Australia entered into free trade agreements (FTAs) with the Republic of Korea and Japan, and concluded an FTA with China, in 2014, adding to existing FTAs with Chile, Malaysia, New Zealand, Singapore, Thailand, and the US, and a regional FTA with ASEAN and New Zealand. Australia continues to negotiate bilateral agreements with India and Indonesia, as well as larger agreements with its Pacific neighbors and the Gulf Cooperation Council countries, and an Asia-wide Regional Comprehensive Economic Partnership that includes the ten ASEAN countries and China, Japan, Korea, New Zealand and India. Australia is also working on the Trans-Pacific Partnership Agreement with Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the US, and Vietnam.

 

Source : CIA

 

Company name

 

ANZCHEM PTY LTD

 

ACN: 103 260 215

ABN: 27 103 260 215

 

 

Summary Panel

 

Established

2002

 

Incorporated

2002

 

Line of Business

Distribution of pharmaceutical, animal health and food ingredients

Status

Trading

Adverse Listings

Nil

 

 

 

EXECUTIVE SUMMARY

 

Anzchem Pty Ltd

 

 

As at 31 August 2014

As at 31 August 2013

Change (%)

Revenue

$14,664,050.00

$16,856,206.00

-13.01%

Profit b/tax

$556,668.00

$1,842,232.00

-69.78%

Profit a/tax

$394,093.00

$1,290,709.00

-69.47%

Net Profit Margin

2.69%

7.66%

-4.97%

 

During fiscal 2014, the subject recorded Net Cashflows from operating activities totalling $1,811,493.

 

As at 31 August 2014 the subject recorded Working Capital of $7,851,743 and a current ratio of 3.61 to 1 indicating strong liquidity levels.

 

Net Assets totalled $8,154,257 as at 31 August 2014. Nil intangibles were recorded at this time.

 

 

CORPORATE SEARCH

 

Company Type             Australian Proprietary Company

 

Status                                       Registered

 

Incorporation Date                     30 December 2002

 

Incorporation State                    VIC

 

Registered Office                      'BUILDING A' LEVEL 1, 11

TALAVERA ROAD NORTH RYDE

NSW, 2113

 

Current Directors Total: 4

Director Name CULLEN, ANDREW GERARD

Appointment Date 18 AUG 2014

Date of Birth 17 OCT 1970

Address 43 DARNLEY ST GORDON NSW 2072

 

Director Name FERNANDO, CHRYSANTHUS

Appointment Date 18 AUG 2014

Date of Birth 13 MAY 1952

Address 88 HIGHS RD WEST PENNANT HILLS, NSW 2125

 

Director Name SINGH, MANJIT

Appointment Date 30 October 2007

Date of Birth 27 March 1955

Place of Birth MOMBASSA KENYA

Gender MALE

Resident Overseas N

Address 7A BERNARD PL,

CHERRYBROOK NSW 2126

Document Number 1F0143681

 

Director Name KAYAL, SHUVASIS RANA

Appointment Date 21 January 2003

Date of Birth 07 February 1961

Place of Birth CALCUTTA INDIA

Gender UNKNOWN

Resident Overseas Y

Address -

Document Number 018863772

 

Current Secretaries Total: 1

Secretary Name CULLEN, ANDREW GERARD

FRANK

Appointment Date 26 February 2013

Date of Birth 17 October 1970

Place of Birth LONDON UNITED KINGDOM

Address 43 DARNLEY STREET GORDON

NSW, 2072

Document Number 1F0467463

 

Company Shares Total: 50000 Amount: $50,000

Class ORDINARY SHARES [ORD]

Number of Shares Issued 50000

Paid Capital $50,000.00

Total Amount Due and Payable $0.00

Document Number 10326021M

 

Current Shareholders

Shareholder Name SPI PHARMA INC

Address 321 CHERRY LANE NEW CASTLE

DE 19720 UNITED STATES

Class ORD

Number Held 50000

Beneficially Held Y

Fully Paid Y

Jointly Held N

Document Number 10326021M

 

 

SECURITY INTERESTS  

 

Effective 30 January 2012 the Personal Property Securities Register (PPSR)  was introduced to give the different Commonwealth, State and Territory laws and registers regarding security interests in personal property under one national system.

 

As a result of PPS Reform a number of existing Commonwealth, State and Territory personal property security registers will close. Interests registered on existing security interest registers will be migrated to the national PPS Register. Subsequently Registered Charges are no longer lodged with the Australian Securities and Investments Commission (ASIC).

 

Please contact us should you require a search of the PPSR.

 

 

BUSINESS STRUCTURE

 

TRADING ADDRESS                 1 Braidwood Street , Enfield

New South Wales, 2136

                                                AUSTRALIA     

 

POSTAL ADDRESS                  5264, Chullora ,

                                                New South Wales , 2190                       

 

TELEPHONE                             (612) 9475 2200

 

FACSIMILE                               (612) 9475 2211

 

EMAIL                                      info@anzchem.com.au

 

WEBSITE                                  www.anzchem.com.au

 

HOLDING ENTITY                      SPI PHARMA INC –USA

 

ULTIMATE HOLDING

ENTITY                         WITTINGTON INVESTMENTS LTD - UK

 

BANK                                       Not determined

                                               

EMPLOYEES                            Not determined

 

 

BACKGROUND

 

The subject was incorporated in New South Wales on 30 December 2002 before adopting the current style on 22 January 2003.

 

The subject was formed in late 2002 as the regional office for SPI Pharma Inc.

 

 

OPERATIONS

 

The subject operates as a supplier of pharmaceuticals, veterinarian and food ingredient products represent a number of renowned international manufacturers

 

Activities are conducted from premises located at the above listed trading address.

 

 

ADVERSE

                                               

A search of of on 19 July 2015 failed to trace any litigation listed against the subject at that date.

 

 

FINANCES

 

During the current investigation contact with the subject’s financial controller was unable to be established. Despite messages left, no reply has been received.

 

From the subjects most recently lodged financial statements, it is noted that for the financial year ended 31 August 2014 the subject recorded revenue of $14,664,050, which resulted in an operating profit before tax of $556,668 and an operating profit after tax of $394,093 representing a Net Profit Margin of 2.7%.

 

Below is a summary of the subject’s income results for the past two financial years.

 

Anzchem Pty Ltd

 

 

As at 31 August 2014

As at 31 August 2013

Change (%)

Revenue

$14,664,050.00

$16,856,206.00

-13.01%

Profit b/tax

$556,668.00

$1,842,232.00

-69.78%

Profit a/tax

$394,093.00

$1,290,709.00

-69.47%

Net Profit Margin

2.69%

7.66%

-4.97%

 

During fiscal 2014, the subject recorded Net Cashflows from operating activities totalling $1,811,493.

 

As at 31 August 2014 the subject recorded total current assets of $10,867,712. They included cash of $5,269,714, receivables of $2,994,219 and inventories of $2,603,779.

 

Current liabilities at the same date totalled $3,015,989 and included payables of $2,728,015.

 

As at 31 August 2014 the subject recorded Working Capital of $7,851,743 and a current ratio of 3.61 to 1 indicating strong liquidity levels.

 

Net Assets totalled $8,154,257 as at 31 August 2014. At this date, the subject further recorded a Debt to Equity ratio of 0.37 to 1 showing low levels of gearing.

 

Anzchem Pty Ltd

 

 

As at 31 August 2014

As at 31 August 2013

Change (%)

Revenue

$14,664,050.00

$16,856,206.00

-13.01%

Profit b/tax

$556,668.00

$1,842,232.00

-69.78%

Profit a/tax

$394,093.00

$1,290,709.00

-69.47%

Net Profit Margin

2.69%

7.66%

-4.97%

Current Assets

$10,867,712.00

$10,850,764.00

0.16%

Non Current Assets

$302,514.00

$253,403.00

19.38%

Total Assets

$11,170,226.00

$11,104,167.00

0.59%

Current Liabilities

$3,015,969.00

$3,224,242.00

-6.46%

Non Current Liabilities

 

$10,461.00

-100.00%

Total Liabilities

$3,015,969.00

$3,234,703.00

-6.76%

Net Assets

$8,154,257.00

$7,869,464.00

3.62%

Working Capital

$7,851,743.00

$7,626,522.00

2.95%

Current Ratio

3.60

3.37

7.07%

Debt to Equity

0.37

0.41

-10.02%

 

 

 

 

TRADE SURVEY

 

Trade payment from further sources in the past 4 months have traced the following data.  

 

Total Owing: $476

Total Past Due: $320

within terms: $156

1 – 30 days past due: $280

31 – 60 days past due: $40

61 – 90 days past due: $0

91+ days: $0

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.23

UK Pound

1

Rs.102.21

Euro

1

Rs.72.57

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

ANK

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.